Innovative Multiomics Strategies to Accelerate Drug Development and Decode Disease Mechanisms
- Discover how molecular signatures across disease phenotypes inform drug response and resistance, with applications beyond primary indications
- Learn how tissue mass spectrometry and long-read sequencing offer deeper insights into disease biology and overcome limitations of traditional short-read approaches
- Explore innovative multiomics frameworks that reveal hidden patterns in unstable and fibrotic disease states, enabling more precise therapeutic development